Volume therapy in cardiac surgery: Does the kind of fluid matter?

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 13, Issue 6, 1999, Pages 752-763

  Boldt, Joachim ^a  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

Author keywords

Albumin; Cardiac; Cardiopulmonary bypass; Crystalloids; Dextran; Gelatin; Hemodynamics; Hydroxyethyl starch; Surgery; Volume replacement

Indexed keywords

ALBUMIN; DEXTRAN; GELATIN; HETASTARCH;

ARTICLE; BODY FLUID; COLLOID; CRYSTALLOID; EXTRACELLULAR FLUID; HEART SURGERY; HUMAN; INTERSTITIAL FLUID; PRIORITY JOURNAL;

EID: 0033461763     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-0770(99)90134-9     Document Type: Article

References (107)

1. Edwards JD: A new debate: Colloid versus colloid?, in Vincent JL (ed): Yearbook of Intensive Care and Emergency Medicine. Berlin, Springer, 1994, pp 152-164
2. Quon CF: Clinical pharmacokinetics and pharmacodynamics of colloidal plasma volume expanders. J Cardiothorac Anesth 2(suppl l):13-23, 1988
3. Velanovich V: Crystalloid versus colloid fluid resuscitation: A meta-analysis of mortality. Surgery 105:65-71, 1989
4. Schlierhout G, Roberts I: Fluid resuscitation with colloids or crystalloids in critically ill patients: A systematic review of randomised trials. BMJ 316:961-964, 1998
5. Cochrane Injuries Group Albumin Reviewers: Human albumin administration in critically ill patients: Systematic review of randomised controlled trials. BMJ 317:235-239, 1998
6. Tonnessen T, Tollofsrud S, Kongsgaard UE, et al: Colloid osmotic pressure of plasma replacement fluids. Acta Anaesthesiol Scaad 37:424-426, 1993
7. Karanko MS, Klossner JA, Laaksonen VO: Restoration of volume by crystalloids versus colloid after coronary artery bypass: Hemodynamics, lung water, oxygenation, and outcome. Crit Care Med 15:559-566, 1987
8. Depoix JP, Pansard Y, Vidocq M, et al: Mesure preoperatoire de la volemie chez les patients devant subir un pontage aorto-coronarien. Ann Franc Anesth Reanimat 2:392-395, 1983
9. Lillehei RC: The nature of irreversible shock. Ann Surg 4:682-686, 1964
10. Edmunds Jr HL: Blood surface interactions during cardiopulmonary bypass. J Cardiac Surg 8:404-420, 1993
11. Butler R, Rocker GM, Westaby S: Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 55:552-559, 1993
12. Casey LC: Role of cytokines in the pathogenesis of cardiopulmonary-induced multisystem organ failure. Ann Thorac Surg 56:S92-S96, 1993
13. Rackow EC, Fein A, Leppo J: Colloid osmotic pressure as a prognostic indicator of pulmonary edema and mortality in the critical ill. Chest 72:709-713, 1977
14. Weil MH, Henning RJ, Puri VK: Colloid oncotic pressure: Clinical significance. Crit Care Med 7:113-120, 1979
15. Morissette M, Weil HW, Shubin H: Reduction in colloid osmotic pressure associated with fatal progression of cardiopulmonary failure. Crit Care Med 3:115-120, 1975
16. Virgilio RW, Rice C, Smith D, et al: Crystalloid vs colloid rescucitation: Is one better? Surgery 2:129-135, 1979
17. Boldt J, Von Bormann B, Kling D, et al: Colloidosmotic pressure and extravascular lung water after extracorporeal circulation. Herz 10:366-375, 1985
18. Connors Jr SF, Speroff T, Dosen MB, et al: The effectiveness of right heart catheterization in the initial care of critically ill patients. JAMA 276:889-897, 1996
19. Hoffman MJ, Greenfield LL, Sugerman HJ, et al: Unsuspected right ventricular dysfunction in shock and sepsis. Nucl Med 198:307-312, 1983
20. Fiddian-Green RG: Gut mucosal ischaemia during cardiac surgery. Semin Thorac Cardiovasc Surg 2:389-399, 1990
21. Mythen MG, Webb AR: The role of gut mucosal hypoperfusion in the pathogenesis of post-operative organ dysfunction. Intensive Care Med 20:203-209, 1994
22. Takala J: Splanchnic perfusion in shock. Intensive Care Med 20:403-404, 1994
23. Mythen MG, Webb AR: Perioperative plasma volume expansion reduces the incidence of gut mucosal hypoperfusion during cardiac surgery. Ann Surg 130:423-429, 1995
24. Bams JL, Mariani MA, Groneveld ABJ: Predicting outcome after cardiac surgery: Comparison of global haemodynamic and tonometric variables. Br J Anaesth 82:33-37, 1999
25. Lamke LO, Liljedahl SO: Plasma volume changes after infusion of various plasma expanders. Resuscitation 5:93-98, 1976
26. Vaupshas HJ, Levy M: Distribution of saline following acute volume loading: Postural effects. Clin Invest Med 13:165-177, 1990
27. Stein L, Berand J, Morisette M: Pulmonary edema during volume infusion. Circulation 52:483-489, 1975
28. Wang P, Hauptman JG, Chaudry IH: Hemorrhage produces depression in microvascular blood flow which persist despite fluid resuscitation. Circ Shock 32:307-318, 1990
29. Giordano JM, Campbell DA, Joseph WL: The effect of intravenously administered albumin on dogs with pulmonary interstitial edema. Surg Gynecol Obstet 137:593-599, 1973
30. Royston D, Minty B, Higenbottom TW, et al: The effect of surgery with cardiopulmonary bypass on alveolar-capillary barrier function in human beings. Ann Thorac Surg 40:139-144, 1985
31. Emmerson TE: Unique features of albumin: A brief review. Crit Care Med 17:690-693, 1989
32. Ernest D, Belzberg AS, Dodeck PM: Distribution of normal saline and 5% albumin infusions in septic patients. Crit Care Med 27:46-50, 1999
33. Kreimeier U, Peter K: Strategies of volume therapy in sepsis and systemic inflammatory response syndrome. Kidney Int 53(suppl 64):75-79, 1998
34. London MJ, Ho SJ, Triedman JK, et al: A randomized clinical trial of 10% pentastarch (low-molecular-weight hydroxyethyl starch) versus 5% albumin for plasma volume expansion after cardiac operations. J Thorac Cardiovasc Surg 97:785-797, 1989
35. Webb AR, Barclay SA, Bennett ED: In vitro colloid osmotic pressure of commonly used plasma substitutes: A study of the diffusibility of colloid molecules. Intensive Care Med 15:116-120, 1989
36. van der Heide RS, Sobotka PA, Gronte CE: Effects of the free radical scavanger DMTU and mannitol on the oxygen paradox in perfused rat hearts. J Mol Cell Cardiol 19:619, 1987
37. Justics AC, Farnsworth WV, Soberman MS: Reduction of myocardial infarct size by poloxamer 188 and mannitol in canine model. Am Heart J 122:671, 1991
38. Cogbill TH, Moore EE, Dunn EL, et al: Coagulation changes after albumin resuscitation. Crit Care Med 9:22-26, 1981
39. Tobias MD, Wambold D, Pilla MA, et al: Differential effects of serial hemodilution with hydroxyethyl starch, albumin, and 0.9% saline on whole blood coagulation. J Clin Anesth 10:366-371, 1998
40. Strauss RG: Review of the effects of hydroxyethyl starch on the blood coagulation system. Transfusion 21:299-309, 1981
41. Wagner BK, D'Amelio LF: Pharmacologic and clinical considerations in selecting crystalloid, colloidal, and oxygen-carrying resuscitation fluids. Part 1. Clin Pharmacol 12:335-346, 1993
42. Sanfelippo MJ, Suberviola PD, Geimer NF: Development of a von Wullebrand-like syndrome after prolonged use of hydroxyethyl starch. Am J Clin Pharmacol 88:653-655, 1987
43. Baron JF: Clinical use of hydroxyethyl starches, in Vincent JL (ed): Update in Intensive Care and Emergency Medicine. Berlin, Springer, 1991, pp 403-414
44. Boldt J, Knothe Ch, Zickmann B, et al: Influence of different intravascular volume therapy on platelet function in patients undergoing cardiopulmonary bypass. Anesth Analg 76:1185-1190, 1993
45. Lacy JH, Wright CB: Use of plasma volume expanders in myocardial revascularisation. Drugs 44:720-727, 1992
46. Warren BB, Durieux ME: Hydroxyethylstarch: Safe or not? Anesth Analg 84:206-212, 1996
47. Treib J, Haass A, Pindur G, et al: All medium starches are not the same: Influence of hydroxyethyl substitution of hydroxyethyl starch on plasma volume, hemorrheologic conditions, and coagulation. Transfusion 36:450-455, 1996
48. Treib J, Haass A, Pindur G: Coagulation disorders caused by hydroxyethyl starch. Thromb Haemost 78:974-983, 1997
49. Bothner U, Georgieff M, Vogt NH: Assessment of the safety and tolerance of 6% hydroxyethylstarch (200/0.5) solution: A randomized, controlled epidemiology study. Anesth Analg 86:850-855, 1998
50. Evans PA, Glenn JR, Heptinstall S, et al: Effects of gelatin-based resuscitation fluids on platelet aggregation. Br J Anaesth 81:198-292, 1998
51. Mardel SN, Saunders FM, Allen H, et al: Reduced quality of clot formation with gelatin-based plasma substitutes. Br J Anaesth 80:204-207, 1998
52. de Jonge E, Levi M, Berends F, et al: Impaired haemostasis by intravenous administration of a gelatin-based plasma expander in human subjects. Thromb Haemost 79:286-290, 1998
53. Lackner FX, Graninger W, Ilias W, et al: Präoperative Eigenblutspende, der Einfluß von Hydroxethylstärke auf Retikuloendothelialsystem und Opsonine. Infusionstherapie 17:276-279, 1990
54. Fisher MM, Brady PW: Adverse reactions to plasma volume expanders. Drug Saf 5:86-93, 1990
55. Paull J: A prospective study of dextran-induced anaphylactoid reactions in 5745 patients. Anaesth Intensive Care 15:165-167, 1987
56. Allhoff T, Lenhart FP: Severe dextran-induced anaphylayctic/ anaphylactoid reaction inspite of hapten prophylaxis. Infusionsther Transfusionsmed 20:301-306, 1993
57. Laxenaire M, Charpentier C, Feldman L: Reactions anaphylactoides aux subitutes colloidaux du plasma: Incidence, facteurs de risque, mecanismes. Ann Fr Anest Reanimat 13:301-310, 1994
58. Moran M, Kapsner C: Acute renal failure associated with elevated plasma oncotic pressure. N Engl J Med 317:150-153, 1987
59. Arfors KE, Buckley P: Pharmacological characteristics of artificial colloids. Baillieres Clin Anaesthesiol 11:15-47, 1997
60. Bazin JE: Pigs are no humans. Br J Anaesth 79:691, 1997
61. Boldt J, von Bormann B, Kling D, et al: Volumenersatz mit einem neuen Hydroxyäthylstärke-Präparat (3% HÄS 200/0.5) in der Herzchirurgie. Infusionstherapie 13:145-151, 1986
62. Boldt J, Kling D, Mühlhause M, et al: Hämodynamische Effekte verschiedener Hydroxyäthylstärke-Lösungen bei kardiochirurgischen Patienten. Anaesthesist 39:6-12, 1990
63. Boldt J, Kling D, Zickmann B, et al: Acute plasmapheresis during cardiac surgery: Volume replacement by crystalloids versus colloids. J Cardiothorac Anesth 4:564-570, 1990
64. Boldt J, Knothe Ch, Zickmann B, et al: Kardiorespiratorische und mikrozirkulatorische Effekte nach Volumenersatz mit einer neuen Hydroxyethylstärke-Präparation. Anaesthesist 41:316-323, 1992
65. Ballesteros M, Boldt J, Zickmann B, et al: Hormonal response to fluid administration in cardiac surgery patients. Perfusion 8:395-392, 1993
66. Boldt J, Zickmann B, Rapin J, et al: Influence of volume replacement with different HES-solutions on microcirculatory blood flow in cardiac surgery. Acta Anaesthesiol Scand 38:432-438, 1994
67. Reed RK, Lilleaaseb P, Lindberg H, et al: Dextran 70 versus donor plasma as colloid in open-heart surgery under extreme haemodilution. Scand J Clin Lab Invest 45:269-274, 1985
68. Sade RM, Stroud MR, Crawford Jr FA, et al: A prospective randomized study on hydroxyethyl starch, albumin, and lactated Ringer's solution as priming fluid for cardiopulmonary bypass. J Thorac Cardiovasc Surg 89:713-722, 1985
69. McKnight Elliott MJ, Pearson DT, et al: The effects of four different crystalloid bypass priming fluid upon the metabolic response to cardiac operation. J Thorac Cardiovasc Surg 90:97-111, 1985
70. Lindberg H, Svennevig LJ, Vatne K, et al: Early postoperative changes with different priming solutions in open-heart surgery. Scand J Thorac Cardiovasc Surg 19:39-44, 1985
71. Lumb PD: A comparison between 25% albumin and 6% hydroxyethylstarch solution on lung water accumulation during and immediately after cardiopulmonary bypass. Ann Surg 206:210-216, 1987
72. Mellbye OJ, Froland SS, Lilleaasen P, et al: Complement activation during cardiopulmonary bypass: Comparison between use of large volumes of plasma and dextran 70. Eur Surg Res 20:101-109, 1988
73. Kongsgaard UE, Smith-Erichson N, Geiran O, et al: Changes in the plasma protease systems during open-heart surgery with dextran vs Ringer's acetate as priming solution. Scand J Thorac Cardiovasc Surg 23:253-258, 1989
74. Bonser RS, Dave JR, Davies ET, et al: Reduction of complement activation during bypass by prime manipulation. Ann Thorac Surg 49:279-283, 1990
75. Marelli D, Paul A, Samson R, et al: Does the addition of albumin to the prime solution in cardiopulmonary bypass affect clinical outcome? A prospective randomized study. J Thorac Cardiovasc Surg 98:751-756, 1989
76. Himpe D, Van Cauwelaert P, Neels H, et al: Priming solutions for cardiopulmonary bypass: Comparison of three colloids. J Cardiothorac Vasc Anesth 5:457-466, 1991
77. Hoeft A, Korb H, Mehlhom U, et al: Priming of cardiopulmonary bypass with human albumin or Ringer's lactate: Effect on colloid osmotic pressure and extravascular lung water. Br J Anaesth 66:73-80, 1991
78. Boldt J, Zickmann B, Benson M, et al: Influence of 5 different priming solutions on platelet function in patients undergoing cardiac surgery. Anesth Analg 74:219-225, 1992
79. London MJ, Franks M, Verrier ED, et al: The safety and efficacy of ten percent pentastarch as a cardiopulmonary bypass priming solution: A randomized clinical trial. J Thorac Cardiovasc Surg 104:284-296, 1992
80. Kuitunen A, Hynyne M, Salmenperä M, et al: Hydroxyethyl starch as a prime for cardiopulmonary bypass: Effects of different solutions on haemostasis. Acta Anaesthesiol Scand 37:652-658, 1993
81. Abott MA, McLaren AD, Algie T: Intra-ocular pressure during cardiopulmonary bypass - a comparison of crystalloid and colloid priming solutions. Anaesthesia 49:343-346, 1994
82. Scott DA, Hore PJ, Cannata J, et al: A comparison of albumin, polygeline and crystalloid priming solutions for cardiopulmonary bypass in patients having coronary artery bypass graft surgery. Perfusion 10:415-424, 1995
83. Tabuchi N, deHaan J, Huet RC, et al: Gelatin use impairs platelet adhesion during cardiac surgery. Thromb Haemost 74:1447-1451, 1995
84. Jansen PG, te Velthuis H, Wildevuur WR, et al: Cardiopulmonary bypass with modified fluid gelatin and heparin-coated circuits. Br J Anaesth 76:13-19, 1996
85. Tigchelaar I, Gallandat Huet RC, Korsten J, et al: Hemostatic effects of three colloid plasma substitutes for priming solution in cardiopulmonary bypass. Eur J Cardiothorac Surg 11:626-632, 1997
86. Buhre W, Hoeft A, Schorn B, et al: Acute effect of mitral valve replacement on extravascular lung water in patients receiving colloid or crystalloid priming of cardiopulmonary bypass. Br J Anaesth 79:311-316, 1997
87. Zornow MH, Prough DS: Fluid management in patients with traumatic brain injury. New Horiz 3:488-498, 1995
88. D'Ambra MN, Philbin DM: Con: Colloids should not be added to the pump prime. J Cardiothorac Anesth 4:406-408, 1990
89. London MJ: Pro: Colloids should be added to the pump prime. J Cardiothorac Anesth 3:401-405, 1990
90. Hett DA, Smith DC: A survey of priming solutions used for cardiopulmonary bypass. Perfusion 9:19-22, 1994
91. Vermeulen LC, Ratko MA, Estad BL, et al: A paradigm for consensus - the university hospital consortium guidelines of the use of albumin, nonprotein colloids, and crystalloid solutions. Arch Intern Med 155:373-379, 1995
92. Gallagher JD, Moore RA, Kerns D, et al: Effects of colloid administration on pulmonary extravascular water in the postoperative period after coronary artery bypass grafting. Anesth Analg 64:753-758, 1985
93. Karanko MS: Effects of three colloid solutions on plasma volume and hemodynamics after coronary artery bypass surgery. Crit Care Med 15:1015-1022, 1987
94. Munsch CM, Maclntyre E, Machin SJ, et al: Hydroxyethyl starch: An alternative to plasma for postoperative volume expansion after cardiac surgery. Br J Surg 75:675-678, 1988
95. Ley SJ, Miller K, Skov P, et al: Crystalloid versus colloid fluid therapy after cardiac surgery. Heart Lung 19:31-40, 1990
96. Brock H, Rapf B, Necek S, et al: Comparison of postoperative volume therapy in heart surgery patients. Anaesthesist 44:486-492, 1995
97. Mastroianni L, Low HB, Rollman J, et al: A comparison of 10% pentastarch and 5% albumin in patients undergoing open-heart surgery. J Clin Pharmacol 34:34-40, 1994
98. Wahba A, Sendtner E, Strotzer W, et al: Fluid therapy with Ringer's solution versus Haemaccel following coronary artery bypass surgery. Acta Anaesthesiol Scand 40:1227-1233, 1996
99. Cope JT, Banks D, Mauney MC, et al: Intraoperative hetastarch infusion impairs hemostasis after cardiac surgery operations. Ann Thorac Surg 63:78-82, 1997
100. Welsby I, Mythen M: Plasma volume support in cardiac surgery. Baillieres Clin Anaesthesiol 11:105-125, 1997
101. Boldt J, Knothe Ch, Schindler E, et al: Volume replacement with hydroxyethylstarch solution in children. Br J Anaesth 70:661-665, 1993
102. Haneda K, Sato S, Ishizawa E, et al: The importance of colloid osmotic pressure during open heart surgery in infants. Tohoku J Exp Med 147:65-71, 1985
103. Ratcliffe JM, Wyse RK, Hunter S, et al: The role of priming fluid in the metabolic response to cardiopulmonary bypass in children of less than 15 kg body weight undergoing open-heart surgery. Thorac Cardiovasc Surg 36:65-74, 1988
104. Auckerman J, Voelpel-Lewis T, Riegger LQ, et al: The relationship between extracorporeal circuit prime, albumin, and postoperative weight gain in children. J Cardiothorac Vasc Anesth 12:409-414, 1998
105. Brutocao D, Bratton SL, Thomas JR, et al: Comparison of hetastarch with albumin for postoperative volume expansion in children after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 10:348-351, 1996
106. London MJ: Plasma volume expansion in cardiovascular surgery: Practical realities, theoretical concerns. J Cardiothorac Anesth 2:39-49, 1988 (suppl 1)
107. Munoz E: Costs of alternative colloid solutions. Infect Surg 12:643-638, 1987